Skip to content

Postoperative INTELLiVENT-ASV Ventilation

The Full Closed Loop Ventilation Mode INTELLiVENT-ASV: User-friendly and Effective Mechanical Ventilation in High Risk Postoperative Patient on the Intensive Care Unit

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03180203
Acronym
POSITiVE
Enrollment
220
Registered
2017-06-08
Start date
2017-05-22
Completion date
2018-06-27
Last updated
2018-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilators, Mechanical, Intensive Care Units, Postoperative Care

Keywords

INTELLiVENT-ASV, Fully closed-loop ventilation, Wean

Brief summary

The aim of this study is to investigate whether postoperative ventilation with INTELLiVENT-ASV(adaptive support ventilation) in high risk patients, after cardiothoracic surgery, is as effective, more user-friendly and as safe as compared to the conventional modes of ventilation.

Detailed description

Recently, Hamilton Medical has introduced the new mechanical ventilation mode INTELLiVENT-ASV. This is a fully closed ventilation mode that can automatically adjust the ventilation settings based on the measured End tidal CO2 (ETCO2) and the measured saturation (SpO2) in both passive and active ventilated patients. Current literature has shown that this mode is safe to use in patients admitted on the intensive care unit. A pilot study in the Catharina Hospital Eindhoven confirmed that in postoperative low risk patients on the intensive care unit INTELLiVENT-ASV is safe. Compared to continuous mandatory or pressure controlled ventilation with pressure support (conventional mechanical ventilation), INTELLiVENT-ASV is even as effective as conventional mechanical ventilation, with a significantly reduced number of interactions with the ventilator. However, available research about the effectiveness of INTELLiVENT-ASV in postoperative high risk patients is lacking. Also the knowledge about the user-friendliness of the above modes of mechanical ventilation for the users is lacking. This is a prospective randomized study with a control group and a intervention group of postoperative high risk patients. Through randomization will be determined whether the participant, after surgery, will be mechanically ventilated with INTELLiVENT-ASV and Quickwean or with conventional mechanical ventilation.

Interventions

After ICU admission: * The first three hours: only ventilation with INTELLiVENT-ASV with Quickwean. * After three hours: Automatic spontaneous breathing trials (SBT) is activated and SBT starts if \>10minutes PEEP:\<9cmH2O,FiO2:\<41%,VT/IBW\<5ml/kg and RSB:\<106l/l\*min. Settings SBT are MV% 25%,PEEP 5cmH2O.SBT automatically stops if respiratory rate \>35b/min or increases \>100% since start of SBT, FiO2 \>50%, PeTCO2 increases \>8mmHg. Extubation criteria: Leakage \<50ml/hr,hemodynamically stable, awake with enough muscle strength and successful SBT \>10min. If during mechanical ventilation the ICU care providers decide that it is necessary for the treatment, they may switch to another ventilation mode or extubate without a SBT.

DEVICEConventional modes

After ICU admission: The first three hours: only ventilation with CMV or PS. If required care providers may change the mode to adaptive support ventilation. After three hours: manual SBT is required if \>10min PS\<11cmH2O,PEEP\<9cmH2O,FiO2\<41%. Settings SBT are PS 5cmH2O, PEEP 5cmH2O, FiO2 30%. SBT must be stopped if respiratory rate \>35b/min or increases \>100% since the start of SBT, saturation \<92% or the PeTCO2 increases \>8mmHg. Extubation criteria: Leakage \<50ml/hr,hemodynamically stable, awake with enough muscle strength and successful SBT \>10min. If during mechanical ventilation the ICU care providers decide that it is necessary for the treatment, they may switch to another ventilation mode or extubate without a SBT.

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
CollaboratorOTHER
Catharina Ziekenhuis Eindhoven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The participant will not know which ventilation mode will be or is used. The primairy investigator and care providers are aware of which ventilation mode is used since it is not possible to blind the care providers because they will need to change ventilating parameters if necessary. The outcome assesor for the percentages of time will be masked. Also are the radiologists, who judge the postoperative thoracic x-ray, masked.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age above 18 years of age. * Informed consent. * Body mass index of \<35 kg/m2. * Mechanical ventilation after elective cardiothoracic surgery. * Admission of the patient after surgery is on the high care unit of the intensive care ward for postoperative mechanical ventilation.

Exclusion criteria

* Withdrawal of consent * Medical history of a pneumonectomy or lobectomy. * The patient wit acute respiratory distress syndrome after surgery. * The patient with a medical history of COPD Gold 3 or 4. * The patient is participating in another postoperative study performed on the intensive care. * The patient is, preoperatively determined, eligible for a fast-track postoperative treatment program on the Post Anesthesia Care Unit.

Design outcomes

Primary

MeasureTime frameDescription
Percentage (%) of mechanical ventilation time in an optimal, acceptable or unacceptable ventilation zone.During the first 3 hours, since admission on the ICU with the start of the intervention ventilation mode.* An optimal zone = Tidal volume (TV) = 4-8 ml/kg of the predicted body weight (PBW) with an EtCO2 = 30-45mmHg, a plateau pressure = \<31cmH2O and SpO2 = 93-98%. * An acceptable zone = TV = 8-12 ml/kg of PBW with an EtCO2 = 25-30 or 45-50mmHg, a plateau pressure = 31-35 cmH2O and SpO2 = 85-93% or \>98%. * An unacceptable zone = TV \>12 ml/kg of PBW or an EtCO2 = \<25 or \>50mmHg, plateau pressure \>35 cmH2O or SpO2 = \<85%.

Secondary

MeasureTime frameDescription
The percentage (%) of successful extubations.During the first 24, 48 and 72 hours after extubationA successful extubation is an extubation without a new intubation or the use of non-invasive ventilation within 24, 48 or 72 hours.
Postoperative weaning time72 hoursThe time from admission on the ICU and a temperature of \>35.5°C until extubation.
Workload72 hoursThe number of alarms and required interactions between the ventilator and the user during mechanical ventilation on the ICU.
UsabilityUp to 1 day after extubationA survey with acceptance score (1-10) completed by the care provider at the bedside who treated the patient for the weaning
Patient agitationUp to 72 hours of mechanical ventilation timeThe number of agitated moments of the patient recognized by the ICU care provider at the bedside.
Administration of sedatives and analgesicsUp to 72 hours of mechanical ventilation timeThe number and dosages of administrations of NSAIDs, opiates, benzodiazepines, clonidine, propofol or haloperidol during mechanical ventilation.
The Richmond Agitation-Sedation Scale (RASS)Up to 72 hours of mechanical ventilation timeThe RASS for every hour during mechanical ventilation.
Postoperative atelectasisUp to 48 hours after extubationThe number of a patients with an atelectasis on the first thoracic x-ray or the thoracic x-ray the following day after surgery.
CO2 levels for postoperative pulmonary shuntingUp to 72 hours of mechanical ventilation timeThe EtCO2/pCO2 ratio during mechanical ventilation.
O2 levels for postoperative pulmonary shuntingUp to 72 hours of mechanical ventilation timeThe pO2/FiO2 ratio during mechanical ventilation.
Reliability of non-invasive oxygen saturation measurement72 hoursThe time of mechanical ventilation on the ICU without non-invasive measurement of the oxygen saturation.

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026